MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
about
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapyIntegrating non-coding RNAs in JAK-STAT regulatory networksCirculating microRNAs as biomarkers for disease staging in multiple sclerosisMicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer.Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancerPolymorphisms in miR-135a-2, miR-219-2 and miR-211 as well as their interaction with cooking oil fume exposure on the risk of lung cancer in Chinese nonsmoking females: a case-control studyModulation of cancer traits by tumor suppressor microRNAs.Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer.Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.miR-135a promotes gastric cancer progression and resistance to oxaliplatin.The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.MicroRNA and signaling pathways in gastric cancer.Propofol protects against hepatic ischemia/reperfusion injury via miR-133a-5p regulating the expression of MAPK6.Global 3' UTR shortening has a limited effect on protein abundance in proliferating T cells.miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1.miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression.Co-occurrence of JAK2 V617F and an uncommon CALR del (p.K368fs*51) mutation facilitates JAK2/STAT signaling in polycythemia vera.Comparative transcriptome analysis to investigate the potential role of miRNAs in milk protein/fat quality.Proposed Molecular and miRNA Classification of Gastric Cancer.Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles
P2860
Q26798420-4502981F-934E-4B12-9F51-A658B265D7A9Q26863279-DBFC3827-F38A-4676-B29E-CEA374220288Q28287246-FD29691F-A920-4073-BCE4-566BDB315C9DQ33845099-F00B8F7C-6F23-4082-9B4E-F62BFAC9714DQ34221779-7D326653-EFA8-45E1-B8B4-00F318F2ACB2Q35051638-998B20A3-35B5-4144-A2A3-10C4C391AD8DQ35201375-F0C9E885-AEDF-4293-B5F7-58FB6D2555E7Q36143366-70134C25-E668-4828-8673-BCC3369D30F9Q36590130-72CD3E16-F568-491F-8205-278F97E22499Q36713518-D63270C9-4AD8-41AA-8D23-EBEF4088ACB7Q37499349-BABBF1DD-65F7-4D61-A332-14A9E42255BFQ37588278-053FB047-CEA1-4D3A-87A4-3BAEE085C50FQ37688600-C5350FC2-2F5B-4664-A8C1-7552DF906C5AQ38208007-89E8BB6F-3A8E-4C57-A60C-067B8E83A8D9Q38233783-45F1CF91-69C8-4674-A9BD-00C189C8150FQ38716418-ADF616A3-5793-4BC2-85BB-68D512EC0732Q38938771-2597B371-A6AC-42E2-8E8A-912F10C2073EQ39026464-E9FC59D1-701E-496C-BA97-3CD81C2EB3D3Q40672156-99BE99C3-0660-4B3D-B6D7-B76654D450BDQ45872619-41DD29CC-EF05-484E-A893-6768C8B4A8E1Q55033537-BA454B23-D455-4F05-A0D0-5EA12C64E3A3Q55385529-3A371938-CCC4-4E50-90AF-FAC53EDB4B03Q55603677-B5A3A40E-D00B-4DE1-B958-83A9165E1F56Q57170401-A3757CC5-BCC2-4B09-9868-7B26C4713F63
P2860
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
@en
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
@nl
type
label
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
@en
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
@nl
prefLabel
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
@en
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
@nl
P2093
P2860
P356
P1476
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
@en
P2093
P2860
P304
P356
10.4161/CBT.18943
P577
2012-03-01T00:00:00Z